Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
Authors:
Open Access
- 31 October 2021
- journal article
- research article
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (5) , 298-305
Abstract
Purpose: Adjuvant chemotherapy (AC) is recommended for patients with stage II colorectal cancer with adverse features. However, the effect of adjuvant treatment in elderly patients with high-risk stage II colorectal cancer remains controversial. This study aimed to investigate the oncologic outcomes in elderly high-risk stage II colorectal cancer patients who underwent curative resection with or without AC.Methods: Patients aged over 70 years having stage II colorectal adenocarcinoma with at least 1 adverse feature who underwent radical surgery between 2008 and 2017 at a single center were included. We compared recurrence-free survival (RFS) and overall survival (OS) between patients who received more than 80% of the planned AC cycle (the AC+ group) and those who did not receive it (the AC− group).Results: The AC+ and AC– group contained 46 patients and 50 patients, respectively. The log-rank test revealed no significant intergroup differences in RFS (P = 0.083) and OS (P = 0.122). In the subgroup of 27 patients with more than 2 adverse features, the AC+ group (n = 16) showed better RFS (P = 0.006) and OS (P = 0.025) than the AC− group. In this subgroup, AC was the only significant factor affecting RFS in the multivariate analysis (P = 0.023). AC was significantly associated with OS (P = 0.033) in the univariate analysis, but not in the multivariate analysis (P = 0.332).Conclusion: Among elderly patients with stage II high-risk colorectal cancer, the AC+ group did not show better RFS or OS than the AC− group. However, selected patients with more than 2 adverse features might benefit from AC.Keywords
This publication has 16 references indexed in Scilit:
- Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National DataCancer Research and Treatment, 2018
- Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon CancerInternational Journal of Gerontology, 2018
- Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general populationCancer, 2017
- Elderly patients with colorectal cancer are oncologically undertreatedEuropean Journal of Surgical Oncology, 2015
- Chemotherapy for colorectal cancer in the elderlyWorld Journal of Gastroenterology, 2015
- Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancerAnz Journal of Surgery, 2013
- Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT DatabaseJournal of Clinical Oncology, 2013
- Efficacy, Compliance and Reasons for Refusal of Postoperative Chemotherapy for Elderly Patients with Colorectal Cancer: A Retrospective Chart Review and Telephone Patient QuestionnairePLOS ONE, 2013
- Changing treatment patterns in elderly patients with resectable colon cancerAsia-Pacific Journal of Clinical Oncology, 2012
- Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapyEuropean Journal of Cancer, 2009